Drug intelligence / Profile preview

moxifloxacin + oleic acid

Development stage
Preclinical
Lead developer
Bayer
Modality
Small Molecules
Administration
Topical
01

Overview

moxifloxacin + oleic acid refers to a novel chemical conjugate, specifically an amide derivative (often designated as 4m in research literature), where the fluoroquinolone antibiotic moxifloxacin is covalently linked to the fatty acid oleic acid. This conjugation strategy is designed to modify the drug's lipophilicity, potentially enhancing its cellular uptake and altering its biological activity. The conjugate has demonstrated potent cytotoxic effects against prostate cancer cell lines (IC50 < 5 µM) and retains significant antibacterial and antimycobacterial properties. Its primary mechanism of action involves the inhibition of bacterial DNA gyrase and topoisomerase IV, which are essential for DNA replication, though its cytotoxic activity in cancer cells suggests additional or modified pathways of action.

Other names
moxifloxacin-oleic acid conjugatemoxifloxacin oleic acid amideCP-4mCP4mCP 4m
02

Targets

Topo IV (Bacterial Topoisomerase IV)DNA gyrase

Beyond the preview

Go deeper on moxifloxacin + oleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on moxifloxacin + oleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call